磷酸化间变性淋巴瘤激酶核相互作用伴侣蛋白抗体

参考价:¥1580
供货周期: 现货
品牌: LMAI Bio
规格: 50ul/100ul/200ul
货号: LM8364R
CAS号:
上海联迈生物工程有限公司
银牌会员7年生产商
关注展位 全部试剂
产品详情

1.png

磷酸化间变性淋巴瘤激酶核相互作用伴侣蛋白抗体

 

英文名称    phospho-NIPA (Ser354)    

中文名称    磷酸化间变性淋巴瘤激酶核相互作用伴侣蛋白抗体    

别    名    NIPA (phospho S354); NIPA (phospho Ser354); p-NIPA (S354); p-NIPA (Ser354); hNIPA; Nuclear interacting partner of ALK; Nuclear interacting partner of anaplastic lymphoma kinase; ZC3HC1; Zinc finger C3HC type containing 1; NIPA_HUMAN.      

产品类型    磷酸化抗体     

研究领域    肿瘤  细胞生物  免疫学  染色质和核信号  信号转导  激酶和磷酸酶      

抗体来源    Rabbit    

克隆类型    Polyclonal    

交叉反应    Human, Mouse, Rat, Dog, Pig, Horse, Rabbit,     

产品应用    WB=1:500-2000 ELISA=1:500-1000  
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.    

分 子 量    55kDa    

细胞定位    细胞核     

性    状    Lyophilized or Liquid    

浓    度    1mg/ml    

免 疫 原    KLH conjugated synthesised phosphopeptide derived from human NIPA around the phosphorylation site of Ser354:TR(p-S)WD     

亚    型    IgG    

纯化方法    affinity purified by Protein A    

储 存 液    0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.    

保存条件    Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.    

PubMed    PubMed    

产品介绍    The regulated oscillation of protein expression is an essential mechanism of cell cycle control. The SCF class of E3 ubiquitin ligases is involved in this process by targeting cell cycle regulatory proteins for degradation by the proteasome, with the F-box subunit of the SCF specifically recruiting a given substrate to the SCF core. NIPA (nuclear interaction partner of ALK) is a human F-box-containing protein that defines an SCF-type E3 ligase (SCFNIPA) controlling mitotic entry. Assembly of this SCF complex is regulated by cell-cycle-dependent phosphorylation of NIPA, which restricts substrate ubiquitination activity to interphase. Nuclear cyclin B1 is a substrate of SCFNIPA. Inactivation of NIPA by RNAi results in nuclear accumulation of cyclin B1 in interphase, activation of cyclin B1-Cdk1 kinase activity, and premature mitotic entry. Thus, SCFNIPA-based ubiquitination may regulate S-phase completion and mitotic entry in the mammalian cell cycle.    


磷酸化间变性淋巴瘤激酶核相互作用伴侣蛋白抗体信息由上海联迈生物工程有限公司为您提供,如您想了解更多关于磷酸化间变性淋巴瘤激酶核相互作用伴侣蛋白抗体报价、型号、参数等信息, 欢迎来电或留言咨询。除供应磷酸化间变性淋巴瘤激酶核相互作用伴侣蛋白抗体外,上海联迈生物工程有限公司还可为您提供MEGF11蛋白抗体、MED6蛋白抗体等产品, 公司有专业的客户服务团队,是您值得信赖的合作伙伴。

相关试剂 更多

相关产品

当前位置: 仪器信息网 LMAI-BIO 试剂 磷酸化间变性淋巴瘤激酶核相互作用伴侣蛋白抗体

关注

拨打电话

留言咨询